Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · IEX Real-Time Price · USD
3.200
+0.020 (0.63%)
May 3, 2024, 4:00 PM EDT - Market closed

RVPH Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
23.3718.5229.698.760
Cash & Cash Equivalents
23.3718.5229.698.760
Cash Growth
26.18%-37.62%238.89%4538999.48%-
Property, Plant & Equipment
00000
Total Assets
23.718.9231.48.760
Accounts Payable
3.853.520.511.010.22
Other Current Liabilities
13.336.441.840.32-
Total Current Liabilities
17.189.962.341.33-
Other Long-Term Liabilities
0.810.570.371.96-
Total Long-Term Liabilities
0.810.570.371.96-
Total Liabilities
17.9810.532.723.36.81
Total Debt
00003.77
Retained Earnings
-134.35-95.09-66.83-58.31-54.53
Shareholders' Equity
5.728.3928.695.47-6.81
Net Cash / Debt
23.3718.5229.698.76-3.76
Net Cash / Debt Growth
26.18%-37.62%238.89%--
Net Cash Per Share
0.980.952.012.86-1.36
Book Value Per Share
0.240.431.941.78-2.46
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).